West Pharmaceutical Services (WST) Receivables (2016 - 2025)
Historic Receivables for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $586.3 million.
- West Pharmaceutical Services' Receivables rose 182.35% to $586.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $586.3 million, marking a year-over-year increase of 182.35%. This contributed to the annual value of $586.3 million for FY2025, which is 182.35% up from last year.
- According to the latest figures from Q4 2025, West Pharmaceutical Services' Receivables is $586.3 million, which was up 182.35% from $652.5 million recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Receivables registered a high of $652.5 million during Q3 2025, and its lowest value of $478.2 million during Q1 2021.
- Its 5-year average for Receivables is $540.7 million, with a median of $536.2 million in 2023.
- In the last 5 years, West Pharmaceutical Services' Receivables soared by 3726.92% in 2021 and then tumbled by 967.97% in 2024.
- West Pharmaceutical Services' Receivables (Quarter) stood at $503.6 million in 2021, then rose by 3.99% to $523.7 million in 2022, then grew by 1.87% to $533.5 million in 2023, then grew by 7.93% to $575.8 million in 2024, then increased by 1.82% to $586.3 million in 2025.
- Its Receivables was $586.3 million in Q4 2025, compared to $652.5 million in Q3 2025 and $610.3 million in Q2 2025.